Literature DB >> 14729948

APRIL-deficient mice have normal immune system development.

Eugene Varfolomeev1, Frank Kischkel, Flavius Martin, Dhaya Seshasayee, Hua Wang, David Lawrence, Christine Olsson, Lucrece Tom, Sharon Erickson, Dorothy French, Peter Schow, Iqbal S Grewal, Avi Ashkenazi.   

Abstract

APRIL (a proliferation-inducing ligand) is a member of the tumor necrosis factor (TNF) superfamily. APRIL mRNA shows high levels of expression in tumors of different origin and a low level of expression in normal cells. APRIL shares two TNF receptor family members, TACI and BCMA, with another TNF homolog, BLyS/BAFF. BLyS is involved in regulation of B-cell activation and survival and also binds to a third receptor, BR3/BAFF-R, which is not shared with APRIL. Recombinant APRIL and BLyS induce accumulation of B cells in mice, while BLyS deficiency results in severe B-cell dysfunction. To investigate the physiological role of APRIL, we generated mice that are deficient in its encoding gene. APRIL(-/-) mice were viable and fertile and lacked any gross abnormality. Detailed histological analysis did not reveal any defects in major tissues and organs, including the primary and secondary immune organs. T- and B-cell development and in vitro function were normal as well, as were T-cell-dependent and -independent in vivo humoral responses to antigenic challenge. These data indicate that APRIL is dispensable in the mouse for proper development. Thus, BLyS may be capable of fulfilling APRIL's main functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729948      PMCID: PMC321448          DOI: 10.1128/MCB.24.3.997-1006.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Optimal preparation of rhesus macaque blood for cytokine flow cytometric analysis.

Authors:  Laurel E Nomura; Eileen D deHaro; Louis N Martin; Holden T Maecker
Journal:  Cytometry A       Date:  2003-05       Impact factor: 4.355

Review 2.  BAFF AND APRIL: a tutorial on B cell survival.

Authors:  Fabienne Mackay; Pascal Schneider; Paul Rennert; Jeffrey Browning
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

3.  Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses.

Authors:  Mercedesz Balázs; Flavius Martin; Tong Zhou; John Kearney
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

4.  NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily.

Authors:  G U von Bülow; R J Bram
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

5.  An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein.

Authors:  B Pradet-Balade; J P Medema; M López-Fraga; J C Lozano; G M Kolfschoten; A Picard; C Martínez-A; J A Garcia-Sanz; M Hahne
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

Review 6.  The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.

Authors:  C A Smith; T Farrah; R G Goodwin
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

7.  Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.

Authors:  Joanna Groom; Susan L Kalled; Anne H Cutler; Carl Olson; Stephen A Woodcock; Pascal Schneider; Jurg Tschopp; Teresa G Cachero; Marcel Batten; Julie Wheway; Davide Mauri; Dana Cavill; Tom P Gordon; Charles R Mackay; Fabienne Mackay
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

8.  Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor.

Authors:  Dhaya Seshasayee; Patricia Valdez; Minhong Yan; Vishva M Dixit; Daniel Tumas; Iqbal S Grewal
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

9.  APRIL modulates B and T cell immunity.

Authors:  Jens V Stein; Marta López-Fraga; Fernando A Elustondo; Carla E Carvalho-Pinto; Dolores Rodríguez; Ruth Gómez-Caro; Joan De Jong; Carlos Martínez-A; Jan Paul Medema; Michael Hahne
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

10.  A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma.

Authors:  Y Laâbi; M P Gras; F Carbonnel; J C Brouet; R Berger; C J Larsen; A Tsapis
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  43 in total

Review 1.  Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.

Authors:  Victor H Engelhard; Anthony B Rodriguez; Ileana S Mauldin; Amber N Woods; J David Peske; Craig L Slingluff
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

2.  TNF superfamily member 13, APRIL, inhibits allergic lung inflammation.

Authors:  Yanping Xiao; Seiichi Motomura; Vadim Deyev; Eckhard R Podack
Journal:  Eur J Immunol       Date:  2010-12-01       Impact factor: 5.532

3.  Reduced APRIL expression induces cellular senescence via a HSPG-dependent pathway.

Authors:  Weifeng Ding; Shaoqing Ju; Shengyang Jiang; Li Zhu; Yueguo Wang; Huimin Wang
Journal:  Pathol Oncol Res       Date:  2009-05-26       Impact factor: 3.201

Review 4.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 5.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

Review 6.  The regulation of gut mucosal IgA B-cell responses: recent developments.

Authors:  N Y Lycke; M Bemark
Journal:  Mucosal Immunol       Date:  2017-07-26       Impact factor: 7.313

Review 7.  BAFF inhibition in SLE-Is tolerance restored?

Authors:  Shaun W Jackson; Anne Davidson
Journal:  Immunol Rev       Date:  2019-09-28       Impact factor: 12.988

Review 8.  [Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis].

Authors:  H-P Hartung
Journal:  Nervenarzt       Date:  2009-12       Impact factor: 1.214

Review 9.  The Role of BAFF System Molecules in Host Response to Pathogens.

Authors:  Jiro Sakai; Mustafa Akkoyunlu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

10.  MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen.

Authors:  Katja Fiedler; Enikö Kokai; Susanne Bresch; Cornelia Brunner
Journal:  Am J Blood Res       Date:  2013-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.